Authors: CLOARECBLANCHARD L

Citation: L. Cloarecblanchard, HEART-RATE AND BLOOD-PRESSURE VARIABILITY IN CARDIAC DISEASES - PHARMACOLOGICAL IMPLICATIONS, Fundamental and clinical pharmacology, 11(1), 1997, pp. 19-28

Authors: CLOARECBLANCHARD L FUNCKBRENTANO C LIPSKI M JAILLON P MACQUINMAVIER I

Citation: L. Cloarecblanchard et al., REPEATABILITY OF SPECTRAL COMPONENTS OF SHORT-TERM BLOOD-PRESSURE ANDHEART-RATE-VARIABILITY DURING ACUTE SYMPATHETIC ACTIVATION IN HEALTHY-YOUNG MALE-SUBJECTS, Clinical science, 93(1), 1997, pp. 21-28

Authors: SAFAR ME CLOARECBLANCHARD L LONDON GM

Citation: Me. Safar et al., ARTERIAL ALTERATIONS IN HYPERTENSION WITH A DISPROPORTIONATE INCREASEIN SYSTOLIC OVER DIASTOLIC BLOOD-PRESSURE, Journal of hypertension, 14, 1996, pp. 103-109

Authors: CLOARECBLANCHARD L FUNCKBRENTANO C CARAYON A JAILLON P

Citation: L. Cloarecblanchard et al., RAPID DEVELOPMENT OF NITRATE TOLERANCE IN HEALTHY-VOLUNTEERS - ASSESSMENT USING SPECTRAL-ANALYSIS OF SHORT-TERM BLOOD-PRESSURE AND HEART-RATE-VARIABILITY, Journal of cardiovascular pharmacology, 24(2), 1994, pp. 266-273

Authors: ELGHOZI JL ELKIK F BAUMELOU A CLOARECBLANCHARD L COPIE X DUBAR M DUTREYDUPAGNE C FOUCHARD M FUNCKBRENTANO C LAURENT S SASSARD J SICHE JP TABONE X VAISSE B VARLAN E

Citation: Jl. Elghozi et al., METHODOLOGY AND EVALUATION OF BLOOD-PRESS URE VARIABILITY, Therapie, 49(3), 1994, pp. 261-266

Authors: DAHAN R JAILLON P LEHNER JP CAZOR JL CLOARECBLANCHARD L DAHAN R DUCHIER J GUINOT P JAILLON P LEHNER JP LOEB F MACQUINMAVIER C PUECH A ROLAND E ROUVEIX B TEULEESPIE M THULLIEZ C VITOU P

Citation: R. Dahan et al., HOW TO PREDICT THE THERAPEUTIC DOSE RANGE TO BE TESTED IN PHASE-III CLINICAL-TRIALS, Therapie, 48(4), 1993, pp. 297-301